Icon

Consensi - (2.5 mg/200 mg, 5 mg/200 mg, 10 mg/200 mg; Tablet)

Amlodipine Besylate and Celecoxib Coeptis Pharma
2.5 mg/200 mg, 5 mg/200 mg, 10 mg/200 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
Consensi is a combination of amlodipine besylate, a calcium channel blocker, and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), indicated for patients for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate.
Yes
***** ** ***. ***** ***** * **** ** ** ******* '***, '***, '*** *** '*** *** *** *********. ** ****** **** **** ***** ****** ** ***** ****. ** *** *** **, **** ***** ******* ***** ****** ******* *** **** ** ****** *******.. *** ******** **** ***** *** **** ******* ******** ** **** ** ******* ****** ***** ** ****** *******’* *.*. ************ *******.
Consensi Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
***** ******* *** ********* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* ***** **, **** ******* **** *** ****** ***** ****
  1. *** *, **** : ***** ******** ***** ****** ***** **'* **** ** ****** ** ******* '*** *** '***
  2. *** **, **** : ***** ****** ***** * **** ******* ***** ** ******* '*** *** '***
  3. *** **, **** : ** *** ***** ******* ***** ****** *** ******* *** **** ** ****** *******.
  4. *** **, **** : ***** ******* **** ****** *******(***** ******)-******* ****** ** *********** *****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.